Emily J. Cicali Schwartz

---

Dr. Emily Jayne Cicali Schwartz is currently a clinical assistant professor at the University of Florida's Department of Pharmacotherapy and Translational Research

Education

Dr. Schwartz graduated with her Bachelor of Science degree in pharmaceutical and Healthcare studies from the Philadelphia College of Pharmacy at University of the Sciences. In 2015, she received her Doctor of Pharmacy degree at Philadelphia College of Pharmacy as well. She then went on to complete her PGY1 residency at Tabula Rasa HealthCare in Geriatric Personalized Medicine in New Jersey. After her residency, Dr. Schwartz spent about another year at Tabula Rasa HealthCare as a clinical research pharmacist. She also held an adjunct faculty position at the Philadelphia College of Pharmacy, which focused on clinical pharmacokinetics and pharmacogenomics implementation. From that experience, Dr. Schwartz found a deep interest and passion for teaching and academia, which lead her to transition into the University of Florida with a fellowship in pharmacogenomics under Dean Johnson. She completed her fellowship as of August 2018.

Research Interest

Dr. Schwartz is currently working on research on inhibitors and substrates and their relationship to medications. She is looking at the pharmacokinetic changes caused by CYP-inhibitors and seeing if primary literature from drug-drug interaction studies matches the FDA definition of the substrates/inhibitors. Dr. Schwartz also focuses on clinical implementation of pharmacogenomics and survey research to patients and prescribers.

Published Works

Peer-Reviewed Biomedical Journals

• Bain KT, Schwartz EJ, Knowlton OV, Knowlton CH, Turgeon J. Implementation of a Pharmacist-Led Pharmacogenomics Service for PACE (PHARM-GENOME-PACE). J Am Pharm Assoc.2018 Mar 27. piiSE1544-3191(18):30076-1.

• Schwartz EJ, Turgeon J,Patel J. et al., Successful Implementation of a Standardized Medication Therapy Management Plus Approach within a Primary Care Setting.J of Amer Board of Family Medicine. 2017 November-December; 30: 701-14.

• Bain KT, Schwartz EJ, Chan-Ting R. Reducing Off-Label Antipsychotic Use in Community-Dwelling Older Adults with Dementia: A Narrative Review. J Am Osteopath Assoc. 2017 July; 117:441-50.

• Schwartz EJ, Issa AM. The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine. Personalized Medicine. Epub 2016 Oct 18.

Papers and Letters

• Schwartz EJ, Steffen LE. FDA Monitors Drug Safety & Long QT. PACE Pharmacy Pages March 2017;3.

• Bain KT, Schwartz EJ, Shah N. The Hefty Price of Hepatitis C Treatment: Can Pharmacogenomics Provide any Relief? PACE Pharmacy Pages April 2016;3-5.

• Schwartz EJ, Bain KT. More Evidence Links Anticholinergic Burden with Poor Outcomes: Summary of New Evidence. PACE Pharmacy Pages October 2015;2-3.

Affiliations

• American College of Clinical Pharmacy (2017 - present)
• International Pharmaceutical Federation (2016 - present)
• Pharmacogenomics Research Network (2016 - present)
• American Society of Clinical Pharmacology and Therapeutics (2015 - present)
• American Society of Consultant Pharmacists (2010 - present)
• American Society of Health-System Pharmacists (2009 - present)

References

This article "Emily J. Cicali Schwartz" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Emily J. Cicali Schwartz. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

---